Michel, Martin C.; Staskin, David
Study Designs for Evaluation of Combination Treatment: Focus on Individual Patient BenefitBIOMEDICINES. Bd. 10. H. 2. 2022
Penner, Inessa; Buescher, Nicole; Dejung, Mario et al.
Subviral Dense Bodies of Human Cytomegalovirus Induce an Antiviral Type I Interferon ResponseCELLS. Bd. 11. H. 24. 2022
Shahneh, F.; Johann, K.; Bohn, T. et al.
Suppression of cAMP formation by inhibitor-loaded polypept(o) ide micelles inhibits melanoma growth by preserving an inflammatory myeloid cell phenotypeEXPERIMENTAL DERMATOLOGY. Bd. 31. H. 2. 2022 S. E48-E48
Ibrahim, Hany S.; Abdelsalam, Mohamed; Zeyn, Yanira et al.
Synthesis, Molecular Docking and Biological Characterization of Pyrazine Linked 2-Aminobenzamides as New Class I Selective Histone Deacetylase (HDAC) Inhibitors with Anti-Leukemic ActivityINTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. Bd. 23. H. 1. 2022
Stickdorn, Judith; Stein, Lara; Arnold-Schild, Danielle et al.
Systemically Administered TLR7/8 Agonist and Antigen-Conjugated Nanogels Govern Immune Responses against TumorsACS NANO. Bd. 16. H. 3. 2022 S. 4426-4443
Rampoldi, Francesca; Donato, Elisa; Ullrich, Leon et al.
T cells license immature B cells to produce a broad range of polyreactive antibodiesCELL REPORTS. Bd. 39. H. 8. 2022
Schwarzenbach, Christian; Tatsch, Larissa; Vilar, Juliana Brandstetter et al.
Targeting c-IAP1, c-IAP2, and Bcl-2 eliminates senescent glioblastoma cells following temozolomide treatmentONCOLOGY RESEARCH AND TREATMENT. Bd. 45. H. SUPPL 3. 2022 S. 49-49
Winkler, Rene; Magdefrau, Ann-Sophie; Piskor, Eva-Maria et al.
Targeting the MYC interaction network in B-cell lymphoma via histone deacetylase 6 inhibitionONCOGENE. Bd. 41. H. 40. 2022 S. 4560-4572
Nandi, Tulika; Puonti, Oula; Clarke, William T. et al.
tDCS induced GABA change is associated with the simulated electric field in M1, an effect mediated by grey matter volume in the MRS voxelBRAIN STIMULATION. Bd. 15. H. 5. 2022 S. 1153-1162
Kaina, Bernd; Beltzig, Lea; Strik, Herwig
Temozolomide - Just a Radiosensitizer?FRONTIERS IN ONCOLOGY. Bd. 12. 2022